TP53 mutations in older adults with acute myeloid leukemia-Reference-Cited by-同舟云学术

TP53 mutations in older adults with acute myeloid leukemia

Published:2016-01-18 Issue:4 Volume:103 Page:429-435
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Yanada Masamitsu^ORCID,Yamamoto Yukiya,Iba Sachiko,Okamoto Akinao,Inaguma Yoko,Tokuda Masutaka,Morishima Satoko,Kanie Tadaharu,Mizuta Shuichi,Akatsuka Yoshiki,Okamoto Masataka,Emi Nobuhiko

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12185-016-1942-1.pdf

Reference35 articles.

1. Juliusson G, Antunovic P, Derolf A, Lehmann S, Mollgard L, Stockelberg D, et al. Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry. Blood. 2009;113:4179–87.

2. Ostgard LS, Norgaard JM, Sengelov H, Severinsen M, Friis LS, Marcher CW, et al. Comorbidity and performance status in acute myeloid leukemia patients: a nation-wide population-based cohort study. Leukemia. 2015;29:548–55.

3. Yanada M, Naoe T. Acute myeloid leukemia in older adults. Int J Hematol. 2012;96:186–93.

4. Farag SS, Archer KJ, Mrozek K, Ruppert AS, Carroll AJ, Vardiman JW, et al. Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461. Blood. 2006;108:63–73.

5. Grimwade D, Walker H, Harrison G, Oliver F, Chatters S, Harrison CJ, et al. The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood. 2001;98:1312–20.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential Correlation between Gene Mutations and Metabolic Changes in Acute Myeloid Leukemia;The Natural Products Journal;2024-10

3. Evaluating targeted therapies in older patients with TP53 -mutated AML;Leukemia & Lymphoma;2024-04-22

4. Recent Advances towards the Understanding of Secondary Acute Myeloid Leukemia Progression;Life;2024-02-27

5. Molecular and clinical significance of FLT3, NPM1, DNMT3A and TP53 mutations in acute myeloid leukemia patients;Molecular Biology Reports;2023-08-04